DWTX — Dogwood Therapeutics, Inc. catalysts
Next verified catalyst
2026-07-01 — Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathi · official source ↗
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-07 (month) in 9d
ESTIMATED |
READOUT
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced
Phase 2 · Chemotherapy Induced Neuropathic Pain, Chemotherapy Induced Pain Neuropathy |
DWTX Dogwood Therapeutics, Inc. | Halneuron, Halneuron (Open Label Extensi |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|